|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Efficacy and safety of a low-dose 24-day combined oral contraceptive |
| containing 20 micrograms ethinylestradiol and 3 micrograms drospirenone. |
| Bachmann G; Sulak PJ; Sampson-Landers C; Benda N; Marr J |
| Contraception. 2004;70:191-198. |
| The aim of this open-label, multicenter, noncomparative study was to determine the efficacy, safety and bleeding |
| profile of a new low-dose, monophasic combined oral contraceptive containing 20 µg ethinylestradiol and 3 mg |
| drospirenone administered daily for 24 days followed by a 4-day hormone-free interval. Contraceptive efficacy was |
| analyzed for 1018 women completing 11,140 treatment cycles. Eleven pregnancies occurred, giving a Pearl Index (PI) |
| of 1.29 (upper limit of the 95% confidence interval [CI], 2.30); of these pregnancies, five were considered due to |
| method failure, giving an adjusted PI of 0.72 (upper limit of the 95% CI, 1.69). A total of 7 (0.7%) women discontinued |
| study medication because of irregular bleeding, suggesting a favorable bleeding profile. Overall, the treatment was |
| well tolerated with an excellent safety profile. The majority of women (86%) stated that they were satisfied or very |
| satisfied with the treatment and over 70% of women would have continued with the study medication. (PubHealth.info |
| Document ID: CONT1T 538-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Efficacy and safety of a low-dose 24-day combined oral |
| contraceptive containing 20 micrograms ethinylestradiol and 3 micrograms drospirenone.", is(are) Bachmann G; |
| Sulak PJ; Sampson-Landers C; Benda N; Marr J. The source of this article is "Contraception. 2004;70:191-198.". |
| This article was published in 2004 in English language(s). (PubHealth.info® Document ID: CONT1T 538-06. All |
| rights reserved with PubHealth.info) PIN: 538 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |